Dr. Devendra Kumar is an Assistant Professor in the Department of Pharmacy. Dr. Kumar did his Ph.D. in Pharmaceutical Sciences from the Indian Institute of Technology (Banaras Hindu University) and completed his postdoctoral research at the University of Texas, USA (2019-2021). His research interest includes Design, Devolvement, and Biological screening of Small molecules, Metal complexes, Peptides for the management of Alzheimer\'s disease, Fragile X Syndrome, and Tuberculosis. Dr. Kumar worked on Alzheimer\'s disease and developed CNS active small molecules such as Acetylcholine, Butyl choline, Beta-secretase 1, Matrix Metalloprotein-2 and 9 inhibitors, and NMDA receptor antagonist. Along with the Drug Discovery, he is also working on the Pathophysiology of Fragile X Syndrome. His work on the Fragile X Syndrome includes identification of spine abnormality and the role of Microglia. The study of Microglia-Neuron communication in genetically modified animals is his thrust area. He is also working on the gene-editing tools using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology and the development of Blood-Brain Barrier penetrating Polymers as a delivery vehicle for CRISPR molecules.